Bharat Immunologicals shows prevailing Real Value of 19.2 per share. The current price of the firm is 22.0. At this time the firm appears to be over valued. Macroaxis approximates value of Bharat Immunologicals from analyzing the firm fundamentals such as Operating Margin of
(5.13)% and Return On Asset of (1.69)% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
|Investment Horizon||30 Days Login to change|
Bharat Immunologicals Biologicals Corp Ltd is rated below average in price to earning category among related companies. It is rated below average in price to sales category among related companies .
Bharat Immunologicals is not very volatile asset. Calculation of real value of Bharat Immunologicals is based on 1 month time horizon. Increasing Bharat Immunologicals time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.